Creatine Kinase-MB
- UID
- IMP/IVD/2023/000171_9343845239eaebeeeecae874a361bc38_b2979d4bd148582f625aa5e837bffc95
- Device class
- Class B
- Brand name
- CLIA
- License holder
- Star Biomed Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- Creatine Kinase-MB (CLIA) is a chemiluminescence immunoassay test for the quantitative measurement of circulating Creatine Kinase MB (CLIA) in human serum, plasma and whole blood, which is intended as an aid to diagnosis of myocardial tissue injury and myocardial infarction
Creatine Kinase-MB is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000171_9343845239eaebeeeecae874a361bc38_b2979d4bd148582f625aa5e837bffc95. This device is marketed under the brand name CLIA. The license holder is Star Biomed Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.